Janik Mark E, Bane Susan L
Department of Chemistry, SUNY-Binghamton, 13902, Binghamton, NY, USA.
Bioorg Med Chem. 2002 Jun;10(6):1895-903. doi: 10.1016/s0968-0896(02)00052-4.
Combretatropone is a hybrid of combretastatin and colchicine in which the o-methoxyphenol of dihydrocombretastatin A-4 is replaced by an alpha-methoxytropone. Derivatives of combretatropone have been synthesized and evaluated for antimicrotubule activity. All combretatropones were less active than the corresponding colchicine derivatives, supporting the idea that loss of ligand conformational entropy upon tubulin binding results in decreased potency for colchicinoid ligands. The structure-activity relationship of the combretatropone series was different than that of the colchicine series. These data indicate that conformationally mobile and conformationally rigid colchicinoids do not interact with the receptor site in the same manner.
康普他曲酮是康普他汀和秋水仙碱的杂合物,其中二氢康普他汀A-4的邻甲氧基苯酚被α-甲氧基托品酮取代。已合成了康普他曲酮的衍生物并对其抗微管活性进行了评估。所有的康普他曲酮的活性均低于相应的秋水仙碱衍生物,这支持了一种观点,即微管蛋白结合时配体构象熵的损失会导致秋水仙碱类配体的效力降低。康普他曲酮系列的构效关系与秋水仙碱系列不同。这些数据表明,构象可移动和构象刚性的秋水仙碱类化合物与受体位点的相互作用方式不同。